GRASP-DM has been designed to help practices to optimise the management and care of patients with diabetes and reduce their risk of developing associated complications. The tool has been used by over 3,200 GP practices.
The tool will also assist with case finding activity, encouraging practices to establish a more accurate prevalence rate and identify patients most at risk of developing the disease.
GRASP-DM quick guide
Find out more about CHART
GRASP access request form
The maintenance and distribution of GRASP-DM is funded by Boehringer Ingelheim Ltd. Boehringer Ingelheim has undertaken a medico legal review, but PRIMIS has retained editorial control and intellectual property rights for the tools.
PRIMIS does not share data with the pharmaceutical industry. With prior agreement and only when specified within a joint working agreement, there may be pre-determined circumstances where aggregated, summative data may be submitted to a pharmaceutical company. The purpose is to assess the success of the joint working project. Please note that this would never involve the reporting of patient or practice level data and would always be supported by a Data Sharing Agreement with the Data Controller (individual GP practice).
This project involves the following PRIMIS services:
Applied Health Research Building
University of Nottingham
Nottingham, NG7 2RD
PRIMIS on Twitter: